{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:39:39Z","timestamp":1765888779609,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejso.2022.01.010","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:24:34Z","timestamp":1642645474000},"page":"1590-1597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-2642","authenticated-orcid":false,"given":"Dario","family":"Baratti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-3943","authenticated-orcid":false,"given":"Pamela","family":"Milito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-910X","authenticated-orcid":false,"given":"Lorena","family":"Martin Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Guaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.01.010_bib1","first-page":"100","article-title":"Klinische and Anastomische Untersuchungen Zur Lehre von der Bauchgeswullsten und der laparotomy","volume":"84","author":"Werth","year":"1884","journal-title":"Arch Gynecol Obstet"},{"article-title":"Classification of Tumours: Digestive System Tumours","year":"2019","series-title":"WHO classification of tumours editorial board","key":"10.1016\/j.ejso.2022.01.010_bib2"},{"key":"10.1016\/j.ejso.2022.01.010_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.01.010_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1245\/s10434-017-6214-7","article-title":"Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei","volume":"25","author":"Choudry","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","article-title":"Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review","volume":"30","author":"Bradley","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.01.010_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","article-title":"Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"249","author":"Baratti","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.010_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductivesurgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/codi.12975","article-title":"The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy","volume":"17","author":"Moran","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2022.01.010_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.23679","article-title":"Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination","volume":"110","author":"Esquivel","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib13","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1245\/s10434-015-5047-5","article-title":"The 7th edition of the AJCC staging classification correlates with biologic behavior of mucinous appendiceal tumor with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC)","volume":"23","author":"Milovanov","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1309\/601K2L2T7CR5U7G1","article-title":"Pleuropulmonary involvement in pseudomyxoma peritonei. Morphologic assessment and literature review","volume":"127","author":"Geisinger","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejso.2022.01.010_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/030089160609200204","article-title":"Splenic metastases from mucinous neoplasms of the appendix and colon","volume":"92","author":"Cabanas","year":"2006","journal-title":"Tumori"},{"key":"10.1016\/j.ejso.2022.01.010_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/690256","article-title":"Pulmonary metastasis from pseudomyxoma peritonei","author":"Kitai","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ejso.2022.01.010_bib17","first-page":"108","article-title":"Pseudomyxoma peritonei metastatic to the bone: case report and review of systemic management","volume":"7","author":"D'Alpino Peixoto","year":"2014","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.ejso.2022.01.010_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.01.010_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","article-title":"Importance of histologic subtype in the staging of appendiceal tumors","volume":"19","author":"Turaga","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib20","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1245\/s10434-016-5350-9","article-title":"Pseudomyxoma peritonei of extra-appendiceal origin: a comparative study","volume":"23","author":"Baratti","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib21","first-page":"49","article-title":"Current methodologies for clinical assessment of patients with peritoneal carcinomatosis","volume":"15","author":"Jaquet","year":"1996","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.ejso.2022.01.010_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jso.21388","article-title":"Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies","volume":"100","author":"Deraco","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib23","unstructured":"https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"10.1016\/j.ejso.2022.01.010_bib24","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2022.01.010_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1245\/s10434-019-07678-0","article-title":"Surveillance of low-grade Appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: are 5 Years enough?","volume":"27","author":"Solomon","year":"2020","journal-title":"A\u00a0Multisite Experience Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","article-title":"Optimal surveillance frequency after CRS\/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC collaborative","volume":"27","author":"Gamboa","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1245\/s10434-006-9174-x","article-title":"Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome","volume":"14","author":"Smeenk","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib28","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","article-title":"Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejso.2016.08.021","article-title":"Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei","volume":"43","author":"Delhorme","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bjs5.97","article-title":"Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"3","author":"Mercier","year":"2018","journal-title":"BJS Open"},{"key":"10.1016\/j.ejso.2022.01.010_bib31","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","article-title":"Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons","volume":"28","author":"Ahmadi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5858\/134.6.864","article-title":"Appendiceal mucinous neoplasms. Controversial issues","volume":"134","author":"Misdraji","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2022.01.010_bib33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2022.01.010_bib34","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u2018\u2018pseudomyxoma peritonei","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am J Surg Pathol"},{"year":"2017","series-title":"American Joint committee on cancer (AJCC) staging manual","key":"10.1016\/j.ejso.2022.01.010_bib35"},{"key":"10.1016\/j.ejso.2022.01.010_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.20038","article-title":"Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process","volume":"86","author":"Faheez","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib37","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1245\/s10434-018-6561-z","article-title":"Preoperative circulating tumor DNA in patients with peritoneal carcinomatosis is an independent predictor of progression-free survival","volume":"25","author":"Baumgartner","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib38","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","article-title":"Toward the molecular dissection of peritoneal pseudomyxoma","volume":"27","author":"Pietrantonio","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2015.12.012","article-title":"Prognostic molecular subtypes of low-grade cancer of the appendix","volume":"222","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.01.010_bib40","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/cancers12061495","article-title":"Improved outcome prediction for appendiceal pseudomyxoma peritonei by integration of cancer cell and stromal transcriptional profiles","volume":"12","author":"Isella","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2022.01.010_bib41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejso.2018.03.031","article-title":"The hepatic bridge","volume":"44","author":"Sugarbaker","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.010_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.21037\/apm.2016.01.03","article-title":"A\u00a0case report of bone metastases from appendiceal adenocarcinoma and a review of literature","volume":"5","author":"Ganesh","year":"2016","journal-title":"Ann Palliat Med"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:45:22Z","timestamp":1760060722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0748798322000130"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}